Latest / Vanguards of Healthcare by Bloomberg Intelligence
Merck’s GHI Fund and the Push to Rewire Pharma's Future
“Our mission is to create both strategic and financial returns by backing scalable technologies that can transform how biopharma operates.” Bill Taranto, president and general partner of the Merck Global Health Innovation Fund, joins Bloomberg Intelligence analyst Jonathan Palmer to break down how Merck’s $600 million evergreen venture arm invests at the intersection of biotech and health tech. Taranto explains why GHI focuses on pharma services across drug development, supply chain, patient access and real-world evidence, how ecosystem investing and private equity drive…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.